PlainPharmaWatch

CMS Open Payments · Program Year 2024

R-Pharm US LLC

R-Pharm US LLC reported $588.45 in payments to 7 physicians and teaching hospitals across 7 transactions.

See the rankings → How this is sourced
$588.45
Total payments
7
Transactions
7
Recipients
+$447.17
General Payments vs PY2022

R-Pharm US LLC reported $588.45 in payments to 7 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1874 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $84.06 per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

R-Pharm US LLC pairs modest payment volume with a moderately concentrated payment pattern.

#1874
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
1
payment categories

Release-over-release change

General Payments changed from PY2022 to PY2024

R-Pharm US LLC's CMS-reported General Payments increased by $447.17 (+316.5%) from PY2022 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: R-PHARM US LLCPY2024: R-Pharm US LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2022 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2022$141.28PY2024$588.45
PY2022
$141.28
PY2024
$588.45

How R-Pharm US LLC ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

R-Pharm US LLC's total vs. every reporting company

CMS Open Payments, Program Year 2024

$588 3rd percentile higher than 3% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). This entry sits in this band. $838–$2,603: 76 reporting companies (4%). Above this entry. $2,603–$8,084: 114 reporting companies (6%). Above this entry. $8,084–$25,112: 167 reporting companies (9%). Above this entry. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for R-Pharm US LLC

Averaging $84.06 per transaction and $84.06 per recipient, R-Pharm US LLC's Program Year 2024 total comes to $588.45 across 7 transactions and 7 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #1874 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Food and Beverage" leads the 1-category general-payment breakdown below at $588.45 (100.0% of the company's reported total, 7 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Across 1 types of general payments, R-Pharm US LLC's largest category was "Food and Beverage" at $588.45 - 100.0% of the company's reported total.

How R-Pharm US LLC divides its payments

General-payment categories, ordered by reported total

1. Food and Beverage$588.45
Payment Type Amount Transactions
Food and Beverage $588.45 7

Recipient Concentration in General Payments

The five largest recipient relationships account for $545.49 (92.7%) of $588.45 in this company's General Payments records across 7 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for R-Pharm US LLC

The five named recipients with the highest reported General Payments from this company

Pedro Gil Solivan Ortiz$151.60Alessandro Santin$137.37Alexander Olawaiye$113.52Nuhad Ibrahim$83.52Mark Shahin$59.48
  1. 1

    Pedro Gil Solivan Ortiz

    $151.60 across 1 reported transactions

  2. 2

    Alessandro Santin

    $137.37 across 1 reported transactions

  3. 3

    Alexander Olawaiye

    $113.52 across 1 reported transactions

  4. 4

    Nuhad Ibrahim

    $83.52 across 1 reported transactions

  5. 5

    Mark Shahin

    $59.48 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $84.06. Average per recipient: $84.06.

Total Amount

$588.45

Avg per Transaction

$84.06

Avg per Recipient

$84.06

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

R-Pharm US LLC Share

0.0%

#1874 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to R-Pharm US LLC

Vantage Technology LLC

$593.80 25 recipients

LumiraDx, Inc.

$600.00 2 recipients

Pixee Medical Inc.

$601.00 2 recipients

Cook Biotech Incorporated

$609.12 1 recipients

curasan, Inc.

$621.57 9 recipients

Nurami Medical Ltd

$627.48 4 recipients

Frequently Asked Questions

How much did R-Pharm US LLC pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $588.45 from R-Pharm US LLC to physicians and hospitals across 7 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from R-Pharm US LLC? ▾
R-Pharm US LLC made payments to 7 physicians and teaching hospitals in 2024. The average payment per recipient was $84.06.
What types of payments did R-Pharm US LLC make? ▾
General payments from R-Pharm US LLC span 1 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Food and Beverage" at $588.45, representing 100.0% of the company's reported total.
How does R-Pharm US LLC rank among pharmaceutical companies? ▾
By total payment amount, R-Pharm US LLC sits at #1874 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from R-Pharm US LLC? ▾
R-Pharm US LLC's 7 transactions to 7 recipients in 2024 averaged $84.06 per transaction.
Where does the payment data for R-Pharm US LLC come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download R-Pharm US LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.